Update On King’s Remoxy – Analyst Blog
On July 2, 2009, King Pharmaceuticals (KG) met with the U.S. Food and Drug Administration (FDA) to discuss the complete response letter regarding the new drug application (NDA) for Remoxy. King is collaborating with Pain...
Read More

